vs

Side-by-side financial comparison of Commerce.com, Inc. (CMRC) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Commerce.com, Inc. is the larger business by last-quarter revenue ($89.5M vs $83.1M, roughly 1.1× PROCEPT BioRobotics Corp). Commerce.com, Inc. runs the higher net margin — -9.3% vs -38.1%, a 28.7% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 2.9%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 5.5%).

SPS Commerce, Inc. is a technology and application software company based in the United States that provides cloud-based supply chain management software. The company's headquarters are located in Minneapolis, Minnesota, but it also has a US office in New Jersey, and international locations in Amsterdam, Beijing, Breukelen, Hong Kong, Kyiv, Melbourne, Montpellier, Sydney, and Toronto.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

CMRC vs PRCT — Head-to-Head

Bigger by revenue
CMRC
CMRC
1.1× larger
CMRC
$89.5M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+17.3% gap
PRCT
20.2%
2.9%
CMRC
Higher net margin
CMRC
CMRC
28.7% more per $
CMRC
-9.3%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
5.5%
CMRC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CMRC
CMRC
PRCT
PRCT
Revenue
$89.5M
$83.1M
Net Profit
$-8.4M
$-31.6M
Gross Margin
78.3%
64.9%
Operating Margin
-7.4%
-4.1%
Net Margin
-9.3%
-38.1%
Revenue YoY
2.9%
20.2%
Net Profit YoY
-250.0%
-27.9%
EPS (diluted)
$-0.11
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMRC
CMRC
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$89.5M
$76.4M
Q3 25
$86.0M
$83.3M
Q2 25
$84.4M
$79.2M
Q1 25
$82.4M
$69.2M
Q4 24
$87.0M
$68.2M
Q3 24
$83.7M
$58.4M
Q2 24
$81.8M
$53.4M
Net Profit
CMRC
CMRC
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-8.4M
$-29.8M
Q3 25
$-2.2M
$-21.4M
Q2 25
$-8.4M
$-19.6M
Q1 25
$-353.0K
$-24.7M
Q4 24
$-2.4M
$-18.9M
Q3 24
$-7.0M
$-21.0M
Q2 24
$-11.3M
$-25.6M
Gross Margin
CMRC
CMRC
PRCT
PRCT
Q1 26
64.9%
Q4 25
78.3%
60.6%
Q3 25
78.4%
64.8%
Q2 25
79.0%
65.4%
Q1 25
79.4%
63.9%
Q4 24
77.6%
64.0%
Q3 24
76.3%
63.2%
Q2 24
75.8%
59.0%
Operating Margin
CMRC
CMRC
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-7.4%
-40.6%
Q3 25
-0.5%
-27.8%
Q2 25
-8.0%
-28.0%
Q1 25
-2.9%
-39.7%
Q4 24
-0.9%
-28.9%
Q3 24
-23.0%
-38.4%
Q2 24
-16.5%
-50.3%
Net Margin
CMRC
CMRC
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-9.3%
-39.1%
Q3 25
-2.6%
-25.7%
Q2 25
-9.9%
-24.7%
Q1 25
-0.4%
-35.8%
Q4 24
-2.7%
-27.6%
Q3 24
-8.4%
-35.9%
Q2 24
-13.8%
-48.0%
EPS (diluted)
CMRC
CMRC
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.11
$-0.54
Q3 25
$-0.03
$-0.38
Q2 25
$-0.10
$-0.35
Q1 25
$0.00
$-0.45
Q4 24
$-0.03
$-0.34
Q3 24
$-0.09
$-0.40
Q2 24
$-0.15
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMRC
CMRC
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$141.1M
$245.6M
Total DebtLower is stronger
$157.0M
$51.7M
Stockholders' EquityBook value
$39.4M
$347.7M
Total Assets
$308.8M
$487.1M
Debt / EquityLower = less leverage
3.99×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMRC
CMRC
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$141.1M
$286.5M
Q3 25
$142.0M
$294.3M
Q2 25
$134.5M
$302.7M
Q1 25
$120.7M
$316.2M
Q4 24
$178.2M
$333.7M
Q3 24
$168.4M
$196.8M
Q2 24
$275.8M
$214.1M
Total Debt
CMRC
CMRC
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$157.0M
$51.6M
Q3 25
$157.3M
$51.6M
Q2 25
$157.5M
$51.5M
Q1 25
$157.8M
$51.5M
Q4 24
$216.5M
$51.5M
Q3 24
$51.4M
Q2 24
$340.9M
$51.4M
Stockholders' Equity
CMRC
CMRC
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$39.4M
$365.9M
Q3 25
$42.8M
$380.3M
Q2 25
$38.8M
$385.8M
Q1 25
$38.1M
$389.2M
Q4 24
$33.4M
$402.2M
Q3 24
$29.0M
$241.2M
Q2 24
$26.1M
$251.8M
Total Assets
CMRC
CMRC
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$308.8M
$508.1M
Q3 25
$309.5M
$511.5M
Q2 25
$302.5M
$513.1M
Q1 25
$286.3M
$519.4M
Q4 24
$340.3M
$534.0M
Q3 24
$335.1M
$374.1M
Q2 24
$452.5M
$374.4M
Debt / Equity
CMRC
CMRC
PRCT
PRCT
Q1 26
0.15×
Q4 25
3.99×
0.14×
Q3 25
3.67×
0.14×
Q2 25
4.06×
0.13×
Q1 25
4.14×
0.13×
Q4 24
6.49×
0.13×
Q3 24
0.21×
Q2 24
13.06×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMRC
CMRC
PRCT
PRCT
Operating Cash FlowLast quarter
$980.0K
Free Cash FlowOCF − Capex
$-2.2M
FCF MarginFCF / Revenue
-2.4%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$16.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMRC
CMRC
PRCT
PRCT
Q1 26
Q4 25
$980.0K
$-10.3M
Q3 25
$10.6M
$-6.6M
Q2 25
$13.6M
$-15.0M
Q1 25
$401.0K
$-17.0M
Q4 24
$12.4M
$-32.4M
Q3 24
$5.6M
$-18.8M
Q2 24
$11.7M
$-15.7M
Free Cash Flow
CMRC
CMRC
PRCT
PRCT
Q1 26
Q4 25
$-2.2M
$-12.2M
Q3 25
$7.6M
$-9.5M
Q2 25
$11.9M
$-17.8M
Q1 25
$-424.0K
$-18.8M
Q4 24
$11.6M
$-33.6M
Q3 24
$4.5M
$-19.0M
Q2 24
$10.7M
$-16.8M
FCF Margin
CMRC
CMRC
PRCT
PRCT
Q1 26
Q4 25
-2.4%
-15.9%
Q3 25
8.8%
-11.4%
Q2 25
14.1%
-22.5%
Q1 25
-0.5%
-27.2%
Q4 24
13.3%
-49.2%
Q3 24
5.4%
-32.6%
Q2 24
13.0%
-31.4%
Capex Intensity
CMRC
CMRC
PRCT
PRCT
Q1 26
Q4 25
3.5%
2.4%
Q3 25
3.4%
3.4%
Q2 25
2.0%
3.5%
Q1 25
1.0%
2.7%
Q4 24
0.9%
1.7%
Q3 24
1.3%
0.4%
Q2 24
1.3%
2.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMRC
CMRC

Subscription And Circulation$65.2M73%
Partner And Services$24.4M27%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons